Wednesday, November 6, 2024
HomeTagsT-Cell Lymphoma

T-Cell Lymphoma

Dialectic Therapeutics Announces DT2216 Has Received Orphan Drug Designation from the FDA for the Treatment of T-Cell Lymphoma

Dialectic Therapeutics, Inc., a Texas-based clinical stage biotechnology company focused on creating innovative new technologies to treat cancer, announced that the U.S. Food and...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics